Attending on behalf of IMA Clinical Research, Alyssa Bochen, PA-C, MMS, CPI, Regional Site Director, and Angel Goewey, MBA, CCRC, Site Director, will join academic investigators, industry scientists, U.S. and international regulators from FDA and EMA, National Institutes of Health components including NIMH, NIDA, NIAAA and many other professionals working in drug development and clinical trials who will all come together to foster improvement in the quality of psychopharmacology practice.

The intersection of technology and best practice leads to breakthroughs within the clinical research enterprise. SCRS West: Clinical Tech & Innovation Summit focuses on new thinking and collaborative problem-solving to power the partnerships research needs in 2025 and beyond. This year, Alyssa Boschen, PA-C, MMS, CPI, Regional Site Director, and Angel Goewey, MBA, CCRC, Site Director, will represent our team. We are excited to announce that Alyssa Boschen will join the panel for 'Assessing Tech Readiness: Site Implementation Checklist'. You won't want to miss this important session!

The ADA's Scientific Sessions is renowned as the global premier diabetes conference, providing a platform to delve into the latest advancements in diabetes research, prevention, and care. IMA Clinical Research is a recognized leader in diabetes research and remains at the forefront of innovative, expert-led practices and cutting-edge developments in diabetes care. Representing IMA at ADA will be Jalene Barnhart, Sr. Director of Business Development; Priya Selvarajah, MD, Regional Site Director; Yumei Liu, MD, Principal Investigator and Lisa Blair, MD, Principal Investigator. Set up a meeting with our team to discuss how we can advance diabetes research together!